BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28479371)

  • 1. UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: A systematic review of UGT isoforms for precision medicine.
    Yang N; Sun R; Liao X; Aa J; Wang G
    Pharmacol Res; 2017 Jul; 121():169-183. PubMed ID: 28479371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases.
    Zhou J; Zhang J; Xie W
    Curr Drug Metab; 2005 Aug; 6(4):289-98. PubMed ID: 16101569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation.
    Burchell B; Brierley CH; Rance D
    Life Sci; 1995; 57(20):1819-31. PubMed ID: 7475929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of the UDP-glucuronosyltransferase transcriptome in human tissues.
    Zhou L; Montalvo AD; Collins JM; Wang D
    Pharmacol Res Perspect; 2023 Dec; 11(6):e01154. PubMed ID: 37983911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Mammalian UDP-Glucuronosyltransferases.
    Wang H; Cao G; Wang G; Hao H
    Curr Drug Metab; 2018; 19(6):490-501. PubMed ID: 29521218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of human UDP-glucuronosyltransferase genes.
    Hu DG; Meech R; McKinnon RA; Mackenzie PI
    Drug Metab Rev; 2014 Nov; 46(4):421-58. PubMed ID: 25336387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of UDP-glucuronosyltransferases (UGTs) by bromophenols (BPs).
    Wang F; Wang S; Yang K; Liu YZ; Yang K; Chen Y; Fang ZZ
    Chemosphere; 2020 Jan; 238():124645. PubMed ID: 31472352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebrate UDP-glucuronosyltransferases: functional and evolutionary aspects.
    Bock KW
    Biochem Pharmacol; 2003 Sep; 66(5):691-6. PubMed ID: 12948849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high throughput assay for the glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin by recombinant human UDP-glucuronosyltransferases and liver microsomes.
    Rahikainen T; Häkkinen MR; Finel M; Pasanen M; Juvonen RO
    Xenobiotica; 2013 Oct; 43(10):853-61. PubMed ID: 23551063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucuronidation in humans. Pharmacogenetic and developmental aspects.
    de Wildt SN; Kearns GL; Leeder JS; van den Anker JN
    Clin Pharmacokinet; 1999 Jun; 36(6):439-52. PubMed ID: 10427468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years.
    Radominska-Pandya A; Bratton S; Little JM
    Curr Drug Metab; 2005 Apr; 6(2):141-60. PubMed ID: 15853765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucuronidation and the UDP-glucuronosyltransferases in health and disease.
    Wells PG; Mackenzie PI; Chowdhury JR; Guillemette C; Gregory PA; Ishii Y; Hansen AJ; Kessler FK; Kim PM; Chowdhury NR; Ritter JK
    Drug Metab Dispos; 2004 Mar; 32(3):281-90. PubMed ID: 14977861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and Protein-Protein Interactions of Human UDP-Glucuronosyltransferases.
    Fujiwara R; Yokoi T; Nakajima M
    Front Pharmacol; 2016; 7():388. PubMed ID: 27822186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A9, and 2B7 and Impacts on Glucuronidation Activity.
    Yuan LM; Gao ZZ; Sun HY; Qian SN; Xiao YS; Sun LL; Zeng S
    Sci Rep; 2016 Nov; 6():34450. PubMed ID: 27857056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Probes for Human UDP-Glucuronosyltransferases: A Comprehensive Review.
    Lv X; Zhang JB; Hou J; Dou TY; Ge GB; Hu WZ; Yang L
    Biotechnol J; 2019 Jan; 14(1):e1800002. PubMed ID: 30192065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of herb-drug / herb interactions between substrates and inhibitors of UGTs derived from herbal medicines.
    Liu D; Zhang L; Duan LX; Wu JJ; Hu M; Liu ZQ; Wang CY
    Pharmacol Res; 2019 Dec; 150():104510. PubMed ID: 31678209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes.
    Kuehl GE; Lampe JW; Potter JD; Bigler J
    Drug Metab Dispos; 2005 Jul; 33(7):1027-35. PubMed ID: 15843492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aflatoxins on UDP-glucuronosyltransferases (UGTs).
    Du Z; Liu ZZ
    Toxicol In Vitro; 2023 Aug; 90():105612. PubMed ID: 37164184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of UDP-glucuronosyltransferases in phytochemical metabolism of herbal medicines and the associated herb-drug interactions.
    Li L; Hu H; Xu S; Zhou Q; Zeng S
    Curr Drug Metab; 2012 Jun; 13(5):615-23. PubMed ID: 22475332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UDP-glucuronosyltransferases 1A6 and 1A10 catalyze reduced menadione glucuronidation.
    Nishiyama T; Ohnuma T; Inoue Y; Kishi T; Ogura K; Hiratsuka A
    Biochem Biophys Res Commun; 2008 Jun; 371(2):247-50. PubMed ID: 18423374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.